According to Cognitive Market Research, the global Theophylline market size will be USD 451.5 million in 2024. It will expand at a compound annual growth rate (CAGR) of 6.50% from 2024 to 2031.
North America held the major market share for more than 40% of the global revenue with a market size of USD 180.60 million in 2024 and will rise at the compound annual growth rate (CAGR) of 4.7% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 135.45 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 103.85 million in 2024 and will rise at the compound annual growth rate (CAGR) of 8.5% from 2024 to 2031.
Latin America had a market share of more than 5% of the global revenue with a market size of USD 22.58 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 9.03 million in 2024 and will rise at the compound annual growth rate (CAGR) of 6.2% from 2024 to 2031.
The Chronic Obstructive Pulmonary Disease (COPD) category is the fastest growing segment of the Theophylline industry
